학술논문
Ruxolitinib as front-line therapy in graft versus host disease: Efficacy and safety in children
Document Type
Article
Author
Source
In Pediatric Hematology Oncology Journal December 2021 6(4):166-170
Subject
Language
ISSN
2468-1245